SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-24-033175
Filing Date
2024-04-16
Accepted
2024-04-16 09:15:02
Documents
1
Group Members
GUY LEVYSOLEUS CAPITAL GROUP, LLCSOLEUS CAPITAL MASTER FUND, L.P.SOLEUS CAPITAL, LLCSOLEUS PE GP I, LLCSOLEUS PRIVATE EQUITY GP I, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D ea0203948-13da4sole_bio.htm SC 13D/A 178375
  Complete submission text file 0001213900-24-033175.txt   180267
Mailing Address C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830
Business Address C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830 475-208-3178
Soleus Private Equity Fund I, L.P. (Filed by) CIK: 0001752427 (see all company filings)

IRS No.: 824521410 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Subject) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91930 | Film No.: 24846235
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)